Knowledge of HPV, its vaccines, and attitudes toward HPV vaccines among obstetrician-gynecologists, pediatricians and immunization services providers in Western China

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, Clifford GM, Franceschi S. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine. 2008;26(Suppl 12):M53–9. doi:10.1016/j.vaccine.2008.05.009.
   PubMedGoogle Scholar
• Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-6.
   PubMed Web of Science ®Google Scholar
• Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human Papillomavirus infection: role of persistence. JNCI J National Cancer Inst. 2010;102(19):1478–88. doi:10.1093/jnci/djq356.
   Web of Science ®Google Scholar
• Medeiros LR, Rosa DD, Da RM, Bozzetti MC, Zanini RR. Efficacy of human papillomavirus vaccines: a systematic quantitative review. Int J Gynecol Cancer. 2009;19(7):1166–76. doi:10.1111/IGC.0b013e3181a3d100.
   PubMed Web of Science ®Google Scholar
• Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P. A pooled analysis of continued prophylactic efficacy of quadrivalent human Papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res. 2009;2(10):868–78. doi:10.1158/1940-6207.CAPR-09-0031.
   PubMed Web of Science ®Google Scholar
• Li W, Nowak G, Jin Y, Cacciatore M. Inadequate and incomplete: Chinese Newspapers’ Coverage of the First Licensed Human Papillomavirus (HPV) Vaccine in China. J HEALTH COMMUN. 2018;23(6):581–90. doi:10.1080/10810730.2018.1493060.
   PubMed Web of Science ®Google Scholar
• Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030–37. doi:10.1002/cncr.32003.
   PubMed Web of Science ®Google Scholar
• Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, Gao C, Ma D, Liao S. Human papillomavirus vaccine against cervical cancer: opportunity and challenge. Cancer Lett. 2020;471:88–102. doi:10.1016/j.canlet.2019.11.039.
   Google Scholar
• China Food and Drug Administration. The license of human papillomavirus bivalent(types 16, 18) vaccine was approved by CFDA. https://www.nmpa.gov.cn/directory/web/nmpa/yaowen/ypjgyw/20191231160701608.html .
   Google Scholar
• Zhang Y, Wang Y, Liu L, Fan Y, Liu Z, Wang Y, Nie S. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. BMC Public Health. 2016;16:216. doi:10.1186/s12889-016-2873-8.
   Web of Science ®Google Scholar
• Abou El Ola M, Rajab M, Abdallah D, Fawaz I, Awad L, Tamim H, Ibrahim A, Mugharbil A, Moghnieh R. Low rate of human papillomavirus vaccination among schoolgirls in Lebanon: barriers to vaccination with a focus on mothers’ knowledge about available vaccines. Ther Clin Risk Manage. 2018;14:617–26. doi:10.2147/TCRM.S152737.
   PubMed Web of Science ®Google Scholar
• Gidengil C, Chen C, Parker AM, Nowak S, Matthews L. Beliefs around childhood vaccines in the United States: a systematic review. VACCINE. 2019;37(45):6793–802. doi:10.1016/j.vaccine.2019.08.068.
   PubMed Web of Science ®Google Scholar
• Liu CR, Liang H, Zhang X, Pu C, Li Q, Li QL, Ren F-Y, Li J. Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China. BMC Public Health. 2019;19(1):488. doi:10.1186/s12889-019-6823-0.
   PubMedGoogle Scholar
• Yu Y, Xu M, Sun J, Li R, Li M, Wang J, Zhang D, Xu A. Human Papillomavirus infection and vaccination: awareness and knowledge of HPV and acceptability of HPV vaccine among mothers of teenage daughters in Weihai, Shandong, China. Plos One. 2016;11(1):e0146741. doi:10.1371/journal.pone.0146741.
   PubMed Web of Science ®Google Scholar
• Li J, Kang LN, Li B, Pang Y, Huang R, Qiao YL. Effect of a group educational intervention on rural Chinese women’s knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines. BMC Cancer. 2015;15:691. doi:10.1186/s12885-015-1682-2.
   PubMed Web of Science ®Google Scholar
• Santhanes D, Wong CP, Yap YY, San SP, Chaiyakunapruk N, Khan TM. Factors involved in human papillomavirus (HPV) vaccine hesitancy among women in the South-East Asian Region (SEAR) and Western Pacific Region (WPR): a scoping review. Hum Vacc Immunother. 2017;14(1):124–33. doi:10.1080/21645515.2017.1381811.
   PubMed Web of Science ®Google Scholar
• Galbraith KV, Lechuga J, Jenerette CM, Moore LAD, Palmer MH, Hamilton JB. Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: a literature review. Soc Sci Med. 2016;159:116–26. doi:10.1016/j.socscimed.2016.04.028.
   PubMed Web of Science ®Google Scholar
• Romaguera J, Caballero-Varona D, Tortolero-Luna G, Marrero E, Suárez E, Pérez CM, Muñoz C, Palefsky J, Ortiz AP. Factors associated with HPV vaccine awareness in a population-based sample of hispanic women in puerto rico. J Racial Ethnic Health Disparities. 2016;3(2):281–90. doi:10.1007/s40615-015-0144-5.
   PubMed Web of Science ®Google Scholar
• Unger Z, Maitra A, Kohn J, Devaskar S, Stern L, Patel A. Knowledge of HPV and HPV vaccine among women ages 19 to 26. Women’s Health Issues. 2015;25(5):458–62. doi:10.1016/j.whi.2015.06.003.
   PubMed Web of Science ®Google Scholar
• Maier C, Maier T, Neagu CE, Vlădăreanu R. Romanian adolescents’knowledge and attitudes towards human papillomavirus infection and prophylactic vaccination. Eur J Obstet Gyn R B. 2015;195:77–82. doi:10.1016/j.ejogrb.2015.09.029.
   PubMed Web of Science ®Google Scholar
• Chang J, Hou Z, Fang H, Meng Q. Are providers’recommendation and knowledge associated with uptake of optional vaccinations among children? A multilevel analysis in three provinces of China. Vaccine. 2019;37(30):4133–39. doi:10.1016/j.vaccine.2019.05.070.
   PubMed Web of Science ®Google Scholar
• Saraiya M, Rosser JI, Cooper CP, Cancers That US. Physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. J Women’s Health. 2012;21(2):111–17. doi:10.1089/jwh.2011.3313.
   PubMed Web of Science ®Google Scholar
• Tolunay O, Celik U, Karaman SS, Celik T, Resitoglu S, Donmezer C, Aydin F, Baspinar H, Mert MK, Samsa H. Awareness and attitude relating to the human papilloma virus and its vaccines among pediatrics, obstetrics and gynecology specialists in Turkey. Asian Pac J Cancer Prev. 2015;15(24):10723–28. doi:10.7314/APJCP.2014.15.24.10723.
   Google Scholar
• McClung NM, Gargano JW, Park IU, Whitney E, Abdullah N, Ehlers S, Bennett NM, Scahill M, Niccolai LM, Brackney M, et al. Estimated number of cases of high-grade cervical lesions diagnosed among Women-United States, 2008 and 2016. MMWR Morb Mortal Wkly Rep. 2019;68(15):337–43. doi:10.15585/mmwr.mm6815a1.
   PubMed Web of Science ®Google Scholar
• Zhu F, Chen W, Hu Y, Hong Y, Li J, Zhang X, Zhang Y-J, Pan Q-J, Zhao F-H, Yu J-X, et al. Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: results from a randomized controlled trial. Int J Cancer. 2014;135(11):2612–22. doi:10.1002/ijc.28897.
   PubMed Web of Science ®Google Scholar
• Lipkind HS, Vazquez-Benitez G, Nordin JD, Romitti PA, Naleway AL, Klein NP, Hechter RC, Jackson ML, Hambidge SJ, Lee GM, et al. Maternal and infant outcomes after human papillomavirus vaccination in the periconceptional period or during pregnancy. Obstet Gynecol. 2017;130(3):599–608. doi:10.1097/AOG.0000000000002191.
   PubMed Web of Science ®Google Scholar
• Shah PD, Calo WA, Gilkey MB, Boynton MH, Alton DS, Todd KG, Robichaud MO, Margolis MA, Brewer NT. Questions and Concerns About HPV Vaccine: a Communication Experiment. PEDIATRICS. 2019;143(2):e20181872. doi:10.1542/peds.2018-1872.
   PubMed Web of Science ®Google Scholar
• Zhao F, Lewkowitz AK, Hu S, Chen F, Li L, Zhang Q, Wu R-F, Li C-Q, Wei L-H, Xu A-D, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. International Journal of Cancer. 2012;131(12):2929–38. doi:10.1002/ijc.27571.
   PubMed Web of Science ®Google Scholar
• Mariani L, Preti M, Cristoforoni P, Stigliano CM, Perino A. Overview of the benefits and potential issues of the nonavalent HPV vaccine. Int J Gynecol Obstet. 2017;136(3):258–65. doi:10.1002/ijgo.12075.
   PubMed Web of Science ®Google Scholar
• Abi Jaoude J, Khair D, Dagher H, Saad H, Cherfan P, Kaafarani MA, Jamaluddine Z, Ghattas H. Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study. Vaccine. 2018;36(49):7562–67. doi:10.1016/j.vaccine.2018.10.065.
   PubMed Web of Science ®Google Scholar